These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 6211134)

  • 41. Comparative activity of beta-lactam antibiotics against 'intrinsically' ticarcillin-resistant strains of Pseudomonas aeruginosa.
    Bert F; Bruneau B; Lambert-Zechovsky N; Branger C
    Chemotherapy; 1994; 40(3):183-7. PubMed ID: 8205936
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vitro activity of furazlocillin (Bay k 4999) compared with those of mezlocillin, piperacillin, and standard beta-lactam antibiotics.
    Gootz TD; Sanders CC; Sanders WE
    Antimicrob Agents Chemother; 1979 Jun; 15(6):783-91. PubMed ID: 475364
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vitro antibacterial activity and susceptibility of cefsulodin, an antipseudomonal cephalosporin, to beta-lactamases.
    King A; Shannon K; Phillips I
    Antimicrob Agents Chemother; 1980 Feb; 17(2):165-9. PubMed ID: 6770753
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparative in vitro activity of LY 127935 (6059-S), seven cephalosporins, three aminoglycosides, carbenicillin, and ticarcillin.
    Watanakunakorn C; Glotzbecker C
    J Antibiot (Tokyo); 1979 Oct; 32(10):1019-24. PubMed ID: 528361
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Synergistic activity between ticarcillin, azlocillin, cefsulodin, ceftazidime and tobramycin or amikacin against Pseudomonas aeruginosa (author's transl)].
    Petit JC; Richard G; Burghoffer B; Daguet GL
    Pathol Biol (Paris); 1982 Jun; 30(6):426-31. PubMed ID: 6810286
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparative in vitro activity of ticarcillin, piperacillin, azlocillin and mezlocillin.
    Chattopadhyay B; Hall I; Curnow SR
    Curr Med Res Opin; 1983; 8(8):577-81. PubMed ID: 6653135
    [TBL] [Abstract][Full Text] [Related]  

  • 47. 3-0-demethyl fortimicin A: in vitro activity and interpretive zone standards for disk diffusion susceptibility tests.
    Barry AL; Jones RN; Thornsberry C; Gavan TL; Gerlach EH; Sommer HM
    Eur J Clin Microbiol; 1984 Dec; 3(6):531-7. PubMed ID: 6441709
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Interpretive standards and quality control guidelines for cefpiramide disk susceptibility tests.
    Barry AL; Gavan TL; Thornsberry C; Jones RN
    J Clin Microbiol; 1985 Oct; 22(4):688-90. PubMed ID: 4077974
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ciprofloxacin disk susceptibility tests: interpretive zone size standards for 5-microgram disks.
    Barry AL; Fass RJ; Anhalt JP; Neu HC; Thornsberry C; Tilton RC; Painter BG; Washington JA
    J Clin Microbiol; 1985 Jun; 21(6):880-3. PubMed ID: 3159749
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The in-vitro activity of mezlocillin against community hospital isolates in comparison to other penicillins and cephalosporins.
    Parry MF; Folta D
    J Antimicrob Chemother; 1983 May; 11 Suppl C():97-102. PubMed ID: 6619043
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sensitivity to carbenicillin and ticarcillin, and the beta-lactamases of Pseudomonas aeruginosa in the UK in 1978-79.
    King JD; Farmer T; Reading C; Sutherland R
    J Clin Pathol; 1980 Mar; 33(3):297-301. PubMed ID: 6769973
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Susceptibility of gram-negative bacteria and Staphylococcus aureus to combinations of ticarcillin and clavulanic acid.
    Casey P; Glauser M
    Eur J Clin Microbiol; 1983 Dec; 2(6):541-7. PubMed ID: 6607834
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vitro activity of piperacillin, ticarcillin, mezlocillin, ticarcillin-clavulanic acid, aztreonam, ceftazidime, azlocillin, cefoperazone, and thienamycin against Pseudomonas aeruginosa.
    Greenberg RN; Bollinger MR; Alivisatos MR
    Clin Ther; 1986; 8(6):655-7. PubMed ID: 3098426
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Activities of new beta-lactam antibiotics against isolates of Pseudomonas aeruginosa from patients with cystic fibrosis.
    Prince AS; Neu HC
    Antimicrob Agents Chemother; 1981 Oct; 20(4):545-6. PubMed ID: 6282199
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Susceptibility of Pseudomonas aeruginosa recently isolated from clinical specimens to various antimicrobial agents and changes of susceptibility to carbenicillin, gentamicin and amikacin (author's transl)].
    Kosakai N; Oguri T
    Jpn J Antibiot; 1980 Jun; 33(6):668-74. PubMed ID: 6779031
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The response of Pseudomonas aeruginosa to azlocillin, ticarcillin and cefsulodin.
    Elliott TS; Greenwood D
    J Med Microbiol; 1983 Aug; 16(3):351-62. PubMed ID: 6410071
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparative in vitro activity of cefepime against nosocomial isolates.
    Sofianou D; Tsoulfa S; Kontodimou L; Polydorou F; Malaka E
    J Chemother; 1997 Oct; 9(5):341-6. PubMed ID: 9373789
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Effect of a ticarcillin-clavulanic acid (timentin) combination on bacteria resistant to ticarcillin].
    Rouhan D; Le Noc P; Robert J
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):461-5. PubMed ID: 3937121
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Azlocillin, mezlocillin, and piperacillin: new broad-spectrum penicillins.
    Eliopoulos GM; Moellering RC
    Ann Intern Med; 1982 Nov; 97(5):755-60. PubMed ID: 6215872
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Azlocillin, a ureido penicillin active against Pseudomonas aeruginosa: interpretive zone standards and quality control parameters for tests with 75-mu g disks.
    Barry AL; Jones RN; Thornsberry C; Gavan TL
    J Clin Microbiol; 1982 Jul; 16(1):135-40. PubMed ID: 6809788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.